AKUMSPharmaceuticals
Akums Drugs & Pharmaceuticals Ltd — Balance Sheet
₹466.10
-3.81%
Akums Drugs & Pharmaceuticals Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Treasury Shares Number | 0.43 Cr | — | — | — | — |
| Ordinary Shares Number | 15.31 Cr | 15.31 Cr | 15.31 Cr | 15.31 Cr | — |
| Share Issued | 15.74 Cr | 15.31 Cr | 15.31 Cr | 15.31 Cr | — |
| Total Debt | 88.21 Cr | 565.23 Cr | 619.09 Cr | 394.98 Cr | — |
| Tangible Book Value | 3.04K Cr | 700.55 Cr | 709.23 Cr | 614.27 Cr | — |
| Invested Capital | 3.06K Cr | 1.20K Cr | 1.25K Cr | 979.93 Cr | — |
| Working Capital | 1.38K Cr | 730.33 Cr | 658.59 Cr | 619.20 Cr | — |
| Net Tangible Assets | 3.04K Cr | 700.55 Cr | 709.23 Cr | 614.27 Cr | — |
| Capital Lease Obligations | 74.56 Cr | 73.67 Cr | 82.12 Cr | 37.03 Cr | — |
| Common Stock Equity | 3.05K Cr | 709.50 Cr | 717.19 Cr | 621.98 Cr | — |
| Total Capitalization | 3.05K Cr | 787.79 Cr | 832.68 Cr | 635.31 Cr | — |
| Total Equity Gross Minority Interest | 3.06K Cr | 720.49 Cr | 723.37 Cr | 625.17 Cr | — |
| Minority Interest | 16.60 Cr | 10.99 Cr | 6.18 Cr | 3.19 Cr | — |
| Stockholders Equity | 3.05K Cr | 709.50 Cr | 717.19 Cr | 621.98 Cr | — |
| Other Equity Interest | 3.02K Cr | — | — | — | — |
| Retained Earnings | 1.83K Cr | 630.85 Cr | 638.54 Cr | 557.63 Cr | — |
| Additional Paid In Capital | 1.08K Cr | 127.17 Cr | 127.17 Cr | 127.17 Cr | — |
| Capital Stock | 30.62 Cr | 28.61 Cr | 28.61 Cr | 14.31 Cr | — |
| Common Stock | 30.62 Cr | 28.61 Cr | 28.61 Cr | 14.31 Cr | — |
| Total Liabilities Net Minority Interest | 1.05K Cr | 2.80K Cr | 2.54K Cr | 2.44K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 156.08 Cr | 1.59K Cr | 1.28K Cr | 1.17K Cr | — |
| Other Non Current Liabilities | 20.56 Cr | 17.43 Cr | 12.89 Cr | 1.57 Cr | — |
| Derivative Product Liabilities | 0.00 | 1.37K Cr | 1.01K Cr | 1.05K Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | 35.90 Cr | 31.02 Cr | 26.23 Cr | 23.93 Cr | — |
| Non Current Deferred Revenue | 13.68 Cr | 13.13 Cr | 15.19 Cr | 11.34 Cr | — |
| Non Current Deferred Taxes Liabilities | 18.62 Cr | 12.15 Cr | 25.30 Cr | 39.30 Cr | — |
| Long Term Debt And Capital Lease Obligation | 67.33 Cr | 146.20 Cr | 190.38 Cr | 43.74 Cr | — |
| Long Term Capital Lease Obligation | 67.33 Cr | 67.91 Cr | 74.88 Cr | 30.41 Cr | — |
| Long Term Debt | 0.00 | 78.30 Cr | 115.50 Cr | 13.33 Cr | — |
| Long Term Provisions | 35.90 Cr | — | — | — | — |
| Current Liabilities | 893.75 Cr | 1.21K Cr | 1.27K Cr | 1.27K Cr | — |
| Other Current Liabilities | 39.14 Cr | 0.10 Cr | 22.51 Cr | — | 0.87 Cr |
| Current Deferred Taxes Liabilities | 0.40 Cr | 1.44 Cr | 18.77 Cr | 47.80 Cr | — |
| Current Debt And Capital Lease Obligation | 20.89 Cr | 419.02 Cr | 428.72 Cr | 351.24 Cr | — |
| Current Capital Lease Obligation | 7.23 Cr | 5.76 Cr | 7.24 Cr | 6.62 Cr | — |
| Current Debt | 13.65 Cr | 413.26 Cr | 421.48 Cr | 344.62 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 15.48 Cr | 11.88 Cr | 2.71 Cr | 3.05 Cr | — |
| Current Provisions | 41.73 Cr | 44.72 Cr | 43.22 Cr | 55.87 Cr | — |
| Payables | 727.38 Cr | 616.31 Cr | 635.78 Cr | 645.29 Cr | — |
| Other Payable | 84.59 Cr | 84.18 Cr | 68.64 Cr | 55.63 Cr | — |
| Total Tax Payable | 0.40 Cr | — | 18.77 Cr | 47.80 Cr | 11.86 Cr |
| Accounts Payable | 642.78 Cr | 532.13 Cr | 567.14 Cr | 589.67 Cr | — |
| Total Assets | 4.11K Cr | 3.52K Cr | 3.27K Cr | 3.07K Cr | — |
| Total Non Current Assets | 1.84K Cr | 1.58K Cr | 1.34K Cr | 1.18K Cr | — |
| Other Non Current Assets | 24.60 Cr | — | — | — | — |
| Non Current Prepaid Assets | 52.79 Cr | 48.06 Cr | 81.59 Cr | 67.91 Cr | — |
| Non Current Deferred Taxes Assets | 208.06 Cr | 123.06 Cr | 31.52 Cr | 18.85 Cr | — |
| Investmentin Financial Assets | 0.29 Cr | 0.30 Cr | 0.21 Cr | 2.84 Cr | — |
| Available For Sale Securities | 0.15 Cr | 0.16 Cr | 0.07 Cr | 2.70 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 0.14 Cr | 0.14 Cr | 0.14 Cr | 0.14 Cr | — |
| Goodwill And Other Intangible Assets | 10.37 Cr | 8.95 Cr | 7.96 Cr | 7.70 Cr | — |
| Other Intangible Assets | 8.30 Cr | 6.88 Cr | 5.90 Cr | 5.64 Cr | — |
| Goodwill | 2.06 Cr | 2.06 Cr | 2.06 Cr | 2.06 Cr | — |
| Net PPE | 1.56K Cr | 1.39K Cr | 1.21K Cr | 1.06K Cr | — |
| Accumulated Depreciation | -783.69 Cr | -646.97 Cr | -539.37 Cr | -460.30 Cr | — |
| Gross PPE | 2.35K Cr | 2.04K Cr | 1.75K Cr | 1.52K Cr | — |
| Construction In Progress | 173.47 Cr | 208.57 Cr | 122.80 Cr | 46.85 Cr | — |
| Other Properties | 228.85 Cr | 205.20 Cr | 315.54 Cr | 252.53 Cr | — |
| Machinery Furniture Equipment | 1.24K Cr | 1.02K Cr | 872.59 Cr | 795.03 Cr | — |
| Buildings And Improvements | 530.03 Cr | 463.58 Cr | 407.03 Cr | 392.18 Cr | — |
| Land And Improvements | 177.94 Cr | 140.43 Cr | 33.72 Cr | 33.64 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 2.27K Cr | 1.94K Cr | 1.92K Cr | 1.89K Cr | — |
| Other Current Assets | 2.24 Cr | 6.61 Cr | 5.10 Cr | 1.10 Cr | — |
| Assets Held For Sale Current | 0.00 | 0.10 Cr | 45.29 Cr | 27.55 Cr | — |
| Prepaid Assets | 231.44 Cr | 182.11 Cr | 129.61 Cr | 152.90 Cr | — |
| Inventory | 680.93 Cr | 630.42 Cr | 729.79 Cr | 722.45 Cr | — |
| Other Inventories | 91.19 Cr | 72.22 Cr | 87.16 Cr | 86.06 Cr | — |
| Finished Goods | 149.98 Cr | 151.62 Cr | 167.57 Cr | 201.56 Cr | — |
| Work In Process | 74.89 Cr | 71.14 Cr | 76.83 Cr | 67.04 Cr | — |
| Raw Materials | 364.87 Cr | 335.44 Cr | 398.24 Cr | 367.80 Cr | — |
| Other Receivables | 7.75 Cr | — | 7.37 Cr | — | 8.00 Cr |
| Accounts Receivable | 770.30 Cr | 833.81 Cr | 845.09 Cr | 884.31 Cr | — |
| Allowance For Doubtful Accounts Receivable | -49.25 Cr | -22.25 Cr | -14.75 Cr | -16.94 Cr | — |
| Gross Accounts Receivable | 819.54 Cr | 856.07 Cr | 859.84 Cr | 901.25 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 581.95 Cr | 287.82 Cr | 150.50 Cr | 103.30 Cr | — |
| Other Short Term Investments | 480.76 Cr | 176.77 Cr | 98.89 Cr | 48.16 Cr | — |
| Cash And Cash Equivalents | 101.19 Cr | 111.05 Cr | 51.61 Cr | 55.14 Cr | — |
| Cash Equivalents | 18.69 Cr | 62.13 Cr | 0.00 | 6.80 Cr | — |
| Cash Financial | 82.50 Cr | 48.91 Cr | 51.61 Cr | 48.34 Cr | — |
| Net Debt | — | 380.50 Cr | 485.37 Cr | 302.81 Cr | 75.00 Cr |
| Long Term Equity Investment | — | 0.00 | 0.00 | 0.24 Cr | 0.39 Cr |
| Investmentsin Associatesat Cost | — | 0.00 | 0.00 | 0.24 Cr | 0.39 Cr |
| Taxes Receivable | — | 0.00 | 11.40 Cr | 0.00 | 0.16 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Akums Drugs & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.